Isometric Versus Isotonic Exercise for Greater Trochanteric Pain Syndrome
Launched by NHS GREATER GLASGOW AND CLYDE · May 8, 2017
Trial Information
Current as of June 24, 2025
Completed
Keywords
ClinConnect Summary
Pain at the side of the hip over or around the greater trochanter of the femur has previously been termed as Greater Trochanteric Pain Syndrome (GTPS). Recent research has found that it is normally due to the gluteal tendons being torn or injured and is often termed as 'gluteal tendinopathy'. GTPS predominantly affects adults aged 40-60 years and is the second most common condition affecting the hip region after osteoarthritis. Quality of life scores are similar to those with advanced hip osteoarthritis but despite its prevalence and disease burden the most effective treatment for this prob...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Able to give written informed consent
- • Lateral hip pain for greater than 3 months
- * Pain on direct palpation of the gluteal tendon insertion on the greater trochanter and additionally at least one of the following pain provocation tests must also be positive:
- • 1. FABER (Flexion, Abduction, External Rotation of the hip)
- • 2. FADER (Flexion, Adduction, External Rotation of the hip)
- • 3. FADER and resisted Internal Rotation (IR) (FADER position plus resisted IR of the hip)
- • 4. Single leg stand for 30 seconds
- • 5. Resisted hip abduction at end-range adduction
- Exclusion Criteria:
- • Physiotherapy for lateral hip pain in the past 6 months
- • Corticosteroid injection for lateral hip pain in past 3 months
- • Inability to actively abduct hip in side-lying
- • Pain reproduced with FADIR (Flexion, Adduction, Internal Rotation of hip) with concurrent hip osteoarthritis on anteroposterior (AP) pelvis x-ray defined as Kellgren-Lawrence \> Grade 2 (mild)
- • Previous hip or lumbar spine surgery in past 12 months
- • Inflammatory joint disease
- • Unstable diabetes or cardiovascular disease
- • Known neurological disorders
- • Widespread chronic pain or fibromyalgia
- • Avascular necrosis
- • Pregnancy
- • Participants unable or unwilling to give informed consent
- • Participants who are unable to write, read or comprehend English
About Nhs Greater Glasgow And Clyde
NHS Greater Glasgow and Clyde (NHS GG&C) is one of the largest health organizations in the UK, dedicated to delivering high-quality healthcare services to a diverse population. As a clinical trial sponsor, NHS GG&C plays a pivotal role in advancing medical research and improving patient outcomes through innovative clinical studies. The organization is committed to upholding rigorous ethical standards and regulatory compliance, ensuring that all trials are conducted with the utmost care for participant safety and scientific integrity. With a focus on collaboration, NHS GG&C partners with academic institutions, healthcare professionals, and industry stakeholders to foster an environment conducive to groundbreaking research and the development of new therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Glasgow, , United Kingdom
Patients applied
Trial Officials
Neal Millar, PhD FRCSEd
Study Director
University of Glasgow
Lorna Paul, MPhil PhD
Study Director
Glasgow Caledonian University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials